neobookRx

Isoniazid Poisoning

Description General measures Medicine treatment Referral T37.1 + (X44.99/X64.99/Y14.99) DESCRIPTION Acute toxicity can present with the classic triad of seizures, metabolic acidosis, and coma. Seizures are of a generalised tonic-clonic type, and often refractory to standard anticonvulsant therapy. GENERAL MEASURES Supportive management aimed at preventing and managing complications. Treat hyperth

Description

General measures

Medicine treatment

Referral


T37.1 + (X44.99/X64.99/Y14.99)

DESCRIPTION

Acute toxicity can present with the classic triad of seizures, metabolic acidosis, and coma. Seizures are of a generalised tonic-clonic type, and often refractory to standard anticonvulsant therapy.

GENERAL MEASURES

Supportive management aimed at preventing and managing complications. Treat hyperthermia.

MEDICINE TREATMENT

For seizures:

  • Pyridoxine, crushed tablets orally or via NGT in unconscious patient(s).
    • Known amount: Pyridoxine dose is 1 g for every gram of isoniazid ingested (maximum of 5 g).
    • Unknown amount: Pyridoxine dose is 5 g for unknown amount ingested.

LoE:IIIaxlix

Benzodiazepines may be used as an interim measure to control seizures:

  • Lorazepam, IV/IM, 4 mg, repeat once after 5–10 minutes, if necessary.

LoE:Ivbl

OR

  • Diazepam, IV, 10 mg, not faster than 2 mg/minute, repeat once after 5–10 minutes if necessary.

OR

  • Clonazepam, IV, 2 mg, repeat once after 5–10 minutes if necessary.

OR

  • Midazolam, IM/IV 10 mg, repeat once after 5–10 minutes if necessary.

OR

  • Midazolam buccal, 10 mg using the parenteral formulation.

CAUTION
Phenytoin should not be used to control seizures in INH poisoning, as it does not have GABA agonist properties.


LoE:IVbli

REFERRAL

  • Uncontrolled seizures

Click here to access the pdf.


Standard Treatment Guidelines and Essential Medicines List for South Africa, Adult Hospital Level, 2020-2024_Version 2.0_27 March 2025

Chapter 19 Poisoning_19.10 Isoniazid Poisoning

Drugs mentioned

ICD-10 codes

NeoHealth® ID 20676 · updated 7/10/2025